Cramer's 'Mad Money' Recap: Merck's Marvelous Template
Click here for an archive of Jim Cramer's Mad Money recaps.
After another day of market nausea, Jim Cramer told viewers of his "Mad Money" TV show that there's only one thing that can protect their capital: dividends.
He told viewers to look for companies with recession-proof businesses that have a good dividend, and a long history of raising that dividend.Cramer used drug maker Merck (MRK) as one shining example for his thesis. Merck currently yields 5.3% with its dividend, and while that's lower that than of Eli Lily (LLY), 5.8%, and Pfizer (PFE), 7.6%, Cramer said Merck is in the best cash position among the three, with a history of boosting its dividend, even during the bad times. Admittedly, 2008 has not been a good year for Merck. There have been many questions swirling around the company's cholesterol drugs Vytorin and Zetia, its HPV and cervical cancer drug Guardasil has seen softer sales due to safety concerns, and it has tussled with the FDA over product labeling. But Cramer said that even at a stripped down valuation, Merck is worth at least $29.90 a share, which is higher than its current value. According to Cramer, Merck has the ability to grow and boost its dividend, even in a weakening economy. The company, which trades at the same level as it did last year, is about halfway through a cost-cutting plan aimed at stripping between $4.5 billion and $5.0 billion from its budget and has higher cash flows than last year. Cramer said Merck's dividend pays investors to wait for the company's valuation to match its stock price. He recommended scaling into a position slowly around Merck's upcoming earnings announcement, and ahead of its analysts conference in December. He said Merck's a buy any time its yield hits 5.5% or higher.
Cramer: Buffett's Buying, But Should You?
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV